FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2289044916> ?p ?o ?g. }

• W2289044916 endingPage "19896" @default.
• W2289044916 startingPage "19884" @default.
• W2289044916 abstract "Triple negative (TNBCs) and the closely related Basal-like (BLBCs) breast cancers are a loosely defined collection of cancers with poor clinical outcomes. Both show strong similarities with BRCA1-mutant breast cancers and BRCA1 dysfunction, or 'BRCAness', is observed in a large proportion of sporadic BLBCs. BRCA1 expression and function has been shown in vitro to modulate responses to radiation and chemotherapy. Exploitation of this knowledge in the treatment of BRCA1-mutant patients has had varying degrees of success. This reflects the significant problem of accurately detecting those patients with BRCA1 dysfunction. Moreover, not all BRCA1 mutations/loss of function result in the same histology/pathology or indeed have similar effects in modulating therapeutic responses. Given the poor clinical outcomes and lack of targeted therapy for these subtypes, a better understanding of the biology underlying these diseases is required in order to develop novel therapeutic strategies.We have discovered a consistent NFκB hyperactivity associated with BRCA1 dysfunction as a consequence of increased Reactive Oxygen Species (ROS). This biology is found in a subset of BRCA1-mutant and triple negative breast cancer cases and confers good outcome. The increased NFκB signalling results in an anti-tumour microenvironment which may allow CD8+ cytotoxic T cells to suppress tumour progression. However, tumours lacking this NFκB-driven biology have a more tumour-promoting environment and so are associated with poorer prognosis. Tumour-derived gene expression data and cell line models imply that these tumours may benefit from alternative treatment strategies such as reprogramming the microenvironment and targeting the IGF and AR signalling pathways." @default.
• W2289044916 created "2016-06-24" @default.
• W2289044916 creator A5005661878 @default.
• W2289044916 creator A5014420290 @default.
• W2289044916 creator A5014851181 @default.
• W2289044916 creator A5034722527 @default.
• W2289044916 creator A5048652049 @default.
• W2289044916 creator A5057625030 @default.
• W2289044916 creator A5067880138 @default.
• W2289044916 creator A5079603792 @default.
• W2289044916 creator A5088266020 @default.
• W2289044916 date "2016-03-02" @default.
• W2289044916 modified "2023-10-18" @default.
• W2289044916 title "A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer" @default.
• W2289044916 cites W1521124448 @default.
• W2289044916 cites W1523531555 @default.
• W2289044916 cites W1967291007 @default.
• W2289044916 cites W1969905647 @default.
• W2289044916 cites W1991221096 @default.
• W2289044916 cites W2007997332 @default.
• W2289044916 cites W2016967137 @default.
• W2289044916 cites W2022176772 @default.
• W2289044916 cites W2026878412 @default.
• W2289044916 cites W2035077913 @default.
• W2289044916 cites W2035924088 @default.
• W2289044916 cites W2040757755 @default.
• W2289044916 cites W2050781188 @default.
• W2289044916 cites W2061123122 @default.
• W2289044916 cites W2066728549 @default.
• W2289044916 cites W2068476548 @default.
• W2289044916 cites W2071036685 @default.
• W2289044916 cites W2074230660 @default.
• W2289044916 cites W2097360283 @default.
• W2289044916 cites W2097539177 @default.
• W2289044916 cites W2098048487 @default.
• W2289044916 cites W2098804778 @default.
• W2289044916 cites W2104519081 @default.
• W2289044916 cites W2105133921 @default.
• W2289044916 cites W2107380545 @default.
• W2289044916 cites W2110177539 @default.
• W2289044916 cites W2111607055 @default.
• W2289044916 cites W2112187879 @default.
• W2289044916 cites W2113904360 @default.
• W2289044916 cites W2115859321 @default.
• W2289044916 cites W2124274605 @default.
• W2289044916 cites W2124392720 @default.
• W2289044916 cites W2124883011 @default.
• W2289044916 cites W2125789330 @default.
• W2289044916 cites W2130598050 @default.
• W2289044916 cites W2131994307 @default.
• W2289044916 cites W2135736714 @default.
• W2289044916 cites W2136902656 @default.
• W2289044916 cites W2139795964 @default.
• W2289044916 cites W2142460765 @default.
• W2289044916 cites W2142739240 @default.
• W2289044916 cites W2145802624 @default.
• W2289044916 cites W2148763013 @default.
• W2289044916 cites W2156924110 @default.
• W2289044916 cites W2161856911 @default.
• W2289044916 cites W2163035374 @default.
• W2289044916 cites W2163563958 @default.
• W2289044916 cites W2166617377 @default.
• W2289044916 cites W2170602872 @default.
• W2289044916 cites W2560367415 @default.
• W2289044916 doi "https://doi.org/10.18632/oncotarget.7865" @default.
• W2289044916 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4991425" @default.
• W2289044916 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26943587" @default.
• W2289044916 hasPublicationYear "2016" @default.
• W2289044916 type Work @default.
• W2289044916 sameAs 2289044916 @default.
• W2289044916 citedByCount "28" @default.
• W2289044916 countsByYear W22890449162017 @default.
• W2289044916 countsByYear W22890449162018 @default.
• W2289044916 countsByYear W22890449162019 @default.
• W2289044916 countsByYear W22890449162020 @default.
• W2289044916 countsByYear W22890449162021 @default.
• W2289044916 countsByYear W22890449162022 @default.
• W2289044916 countsByYear W22890449162023 @default.
• W2289044916 crossrefType "journal-article" @default.
• W2289044916 hasAuthorship W2289044916A5005661878 @default.
• W2289044916 hasAuthorship W2289044916A5014420290 @default.
• W2289044916 hasAuthorship W2289044916A5014851181 @default.
• W2289044916 hasAuthorship W2289044916A5034722527 @default.
• W2289044916 hasAuthorship W2289044916A5048652049 @default.
• W2289044916 hasAuthorship W2289044916A5057625030 @default.
• W2289044916 hasAuthorship W2289044916A5067880138 @default.
• W2289044916 hasAuthorship W2289044916A5079603792 @default.
• W2289044916 hasAuthorship W2289044916A5088266020 @default.
• W2289044916 hasBestOaLocation W22890449161 @default.
• W2289044916 hasConcept C104317684 @default.
• W2289044916 hasConcept C121608353 @default.
• W2289044916 hasConcept C126322002 @default.
• W2289044916 hasConcept C127716648 @default.
• W2289044916 hasConcept C154317977 @default.
• W2289044916 hasConcept C167672396 @default.
• W2289044916 hasConcept C202751555 @default.
• W2289044916 hasConcept C203014093 @default.
• W2289044916 hasConcept C2776107976 @default.

• next